ORMP - Oramed's subsidiary inks purchase deal for 10M doses of oral COVID-19 vaccines in Southeast Asia

Oramed Pharmaceuticals' (NASDAQ:ORMP) subsidiary, Oravax Medical, has signed a Cooperation and Purchase Agreement with Vietnam-based Tan Thanh Holdings Investment Joint Stock Company to pre-purchase Oravax's oral COVID-19 vaccine, currently in development. The agreement grants Tan Thanh Holdings the right to sell Oravax's oral vaccine throughout the Association of Southeast Asian Nations (ASEAN) which includes Vietnam, Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar, the Philippines, Singapore and Thailand. The Agreement is for an initial pre-order of 10M doses of oral COVID-19 vaccines from Oravax and is comprised of milestone payments. The parties have agreed to negotiate follow-on orders potentially worth hundreds of millions of dollars.

For further details see:

Oramed's subsidiary inks purchase deal for 10M doses of oral COVID-19 vaccines in Southeast Asia